These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 30542637)

  • 1. A Rare Instance of Simultaneous Infection with Disseminated Nocardia and Pulmonary Aspergillus in a Patient Receiving Treatment with Ibrutinib for Chronic Lymphocytic Leukemia.
    Dotson J; Katz H; Jafri H; Jamil MO; Willenburg KS
    Cureus; 2018 Oct; 10(10):e3427. PubMed ID: 30542637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy.
    Voshtina E; Huang H; Raj R; Atallah E
    Case Rep Hematol; 2018; 2018():6514604. PubMed ID: 30155323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia.
    Arthurs B; Wunderle K; Hsu M; Kim S
    Respir Med Case Rep; 2017; 21():27-29. PubMed ID: 28377877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is ibrutinib associated with disseminated cryptococcosis with CNS involvement?
    Abid MB; Stromich J; Gundacker ND
    Cancer Biol Ther; 2019; 20(2):138-140. PubMed ID: 30148696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal Cryptococcal Meningitis in a Patient With Chronic Lymphocytic Leukemia Treated With Ibrutinib.
    Oumayma H; Mahtat EM; Moussa Bouh H; Elmaaroufi H; Doghmi K
    Cureus; 2023 Apr; 15(4):e37891. PubMed ID: 37213990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic evaluation of ibrutinib for the treatment of chronic lymphocytic leukemia: rationale for lower doses.
    Bose P; Gandhi VV; Keating MJ
    Expert Opin Drug Metab Toxicol; 2016 Nov; 12(11):1381-1392. PubMed ID: 27686109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus Proctitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: A Case Report.
    Reddy Y; Baig M; Kalva N; Puli S; Dhillon S
    Cureus; 2020 Apr; 12(4):e7837. PubMed ID: 32467812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review.
    Mannina D; Loteta B
    Case Rep Hematol; 2017; 2017():9583257. PubMed ID: 28791187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy.
    Eichenberger EM; Saullo J; Brander D; Wang SH; Perfect JR; Messina JA
    Med Mycol Case Rep; 2020 Mar; 27():17-21. PubMed ID: 31879587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Barrientos JC; O'Brien S; Brown JR; Kay NE; Reddy NM; Coutre S; Tam C; Mulligan S; Jaeger U; Devereux S; Pocock C; Robak T; Schuster SJ; Schuh A; Gill D; Bloor A; Dearden C; Moreno C; Cull G; Hamblin M; Jones JA; Eckert K; Solman IG; Suzuki S; Hsu E; James DF; Byrd JC; Hillmen P
    Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):803-813.e7. PubMed ID: 30249389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranous nephropathy in chronic lymphocytic leukemia responsive to ibrutinib: A case report.
    Turcotte AE; Glass WF; Lin JS; Burger JA
    Leuk Res Rep; 2023; 20():100377. PubMed ID: 37457553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-fungal sepsis and mucormycosis of the central nervous system in a patient treated with ibrutinib, a case report and review of the literature.
    Fehr M; Cathomas G; Graber A; Makert E; Gaus E; Boggian K
    Med Mycol Case Rep; 2020 Mar; 27():14-16. PubMed ID: 31890489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated Cryptococcal Infection in Treatment-Naive Patients With Chronic Lymphocytic Leukemia (CLL).
    Gujabidze K; Hussain SA; Balint S; Saadeh B; Yucelen S; Shiferaw B
    Cureus; 2024 Apr; 16(4):e59022. PubMed ID: 38800240
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Roberts AL; Davidson RM; Freifeld AG; Iwen PC
    IDCases; 2016; 6():68-71. PubMed ID: 27747160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
    Maddocks K; Jones JA
    Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartic Aminopeptidase Is a Novel Biomarker of Aggressive Chronic Lymphocytic Leukemia.
    Kakodkar P; More S; András K; Papakonstantinou N; Kelly S; Makrooni MA; Ortutay C; Szegezdi E
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy.
    Al-Katib AM; Gaith H; Sano D; Al-Katib S; Bonnett M; Kafri Z
    Clin Case Rep; 2020 Sep; 8(9):1797-1801. PubMed ID: 32983498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated Nocardia cyriacigeorgica Infection Disguised as a Metastatic Adrenal Gland Malignancy in a Healthy Patient.
    Daniel M; Salman S; Adam B
    Cureus; 2024 Jul; 16(7):e63693. PubMed ID: 38957514
    [No Abstract]   [Full Text] [Related]  

  • 19. A case report of disseminated nocardiosis with ocular involvement in a myasthenia gravis patient and literature review.
    Wang S; Jiang B; Li Y; Shang Y; Liu Z; Zhang Y
    BMC Neurol; 2019 Oct; 19(1):243. PubMed ID: 31638926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated nocardiosis due to unusual species: two case reports.
    Alp E; Yildiz O; Aygen B; Sumerkan B; Sari I; Koc K; Couble A; Laurent F; Boiron P; Doganay M
    Scand J Infect Dis; 2006; 38(6-7):545-8. PubMed ID: 16798710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.